Market Intelligence
Healthcare Information and Communication Technology Philippines Trade Development

Philippines Healthcare Digital Therapeutics

The Philippines’ fast-growing Digital Therapeutics (DTx) market presents strong opportunities for U.S. innovators, particularly in chronic disease management, mental health, and preventive care. U.S. firms can leverage the emerging DTx segment in the Philippine healthcare market and help deliver evidence-based healthcare through mobile applications, wearable devices, and cloud platforms, making this innovative, applicable, scalable, and accessible even in rural and far-flung areas.

The Philippine DTx market was valued at $14 million in 2023 and is estimated to grow to $77.5 million by 2030, according to Insights10. While adoption in the Philippines is in its early stages, growth is expected to accelerate due to rising mental health awareness, increasing prevalence of chronic non-communicable diseases (NCDs), and higher mobile penetration in rural areas.

Chronic disease management is one of the most promising segments for U.S. companies. Non-communicable diseases such as diabetes, hypertension, obesity, and asthma are the leading causes of death in the Philippines. As an archipelagic country, the Philippines faces healthcare access challenges; DTx tools can help bridge these gaps by enabling remote monitoring of vital signs and other health data in real time.

Current prominent players in the Philippine DTx market include KonsultaMD, MediCard, WellDoc, and Canary Health. There is room for more specialized solutions targeting cardiovascular health, respiratory conditions, weight management, mental health, and post-acute care rehabilitation.

Entry Strategies for U.S. Companies

  • Partner with Hospitals and HMOs: Collaborations with private healthcare providers can allow DTx companies to pilot their solutions and adapt them to local clinical settings.
  • Engage Wellness Providers and Fitness Platforms: Bundling DTx with preventive health services can expand user reach.
  • Collaborate with Progressive LGUs: Forward-looking local government units are investing in tech-enabled health programs that can integrate DTx.
  • Localize Content: Adapt user interfaces and educational materials into Filipino or other regional dialects to improve accessibility and engagement.

Currently, there is no dedicated regulatory pathway for registering DTx solutions. The framework for Software as a Medical Device (SaMD) is still being developed and has undergone consultation with relevant stakeholders. DTx treatments are not yet covered under the Philippines’ national health insurance program (PhilHealth), limiting affordability for lower-income populations.

The U.S. Commercial Service can help U.S. companies navigate the Philippine healthcare and ICT markets, identify local partners, and understand the Philippine business environment. Please get in touch with Katrina Domingo, Commercial Specialist for Healthcare at Katrina.Domingo@trade.gov and Easter Villanueva, Commercial Specialist, Digital Technologies or ICT at Easter.Villanueva@trade.gov.

If you need help to choose your industry and trade topic selections, email Paul.Oliva@trade.gov.